Logo image of COST

COSTCO WHOLESALE CORP (COST) Stock Fundamental Analysis

NASDAQ:COST - US22160K1051 - Common Stock

958.54 USD
-11.14 (-1.15%)
Last: 8/22/2025, 8:00:36 PM
958.177 USD
-0.36 (-0.04%)
After Hours: 8/22/2025, 8:00:36 PM
Fundamental Rating

6

Taking everything into account, COST scores 6 out of 10 in our fundamental rating. COST was compared to 40 industry peers in the Consumer Staples Distribution & Retail industry. COST has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, COST is valued expensive at the moment. This makes COST very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year COST was profitable.
COST had a positive operating cash flow in the past year.
Each year in the past 5 years COST has been profitable.
In the past 5 years COST always reported a positive cash flow from operatings.
COST Yearly Net Income VS EBIT VS OCF VS FCFCOST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

Looking at the Return On Assets, with a value of 10.39%, COST belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
With an excellent Return On Equity value of 28.91%, COST belongs to the best of the industry, outperforming 85.00% of the companies in the same industry.
COST's Return On Invested Capital of 19.92% is amongst the best of the industry. COST outperforms 100.00% of its industry peers.
COST had an Average Return On Invested Capital over the past 3 years of 18.60%. This is significantly above the industry average of 8.22%.
The last Return On Invested Capital (19.92%) for COST is above the 3 year average (18.60%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.39%
ROE 28.91%
ROIC 19.92%
ROA(3y)9.59%
ROA(5y)8.89%
ROE(3y)28.2%
ROE(5y)27%
ROIC(3y)18.6%
ROIC(5y)17.81%
COST Yearly ROA, ROE, ROICCOST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 2.92%, COST is in the better half of the industry, outperforming 77.50% of the companies in the same industry.
COST's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 3.75%, COST is doing good in the industry, outperforming 70.00% of the companies in the same industry.
COST's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 12.78%, COST is doing worse than 82.50% of the companies in the same industry.
COST's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.75%
PM (TTM) 2.92%
GM 12.78%
OM growth 3Y-0.72%
OM growth 5Y3.3%
PM growth 3Y4.25%
PM growth 5Y3.86%
GM growth 3Y-0.71%
GM growth 5Y-0.57%
COST Yearly Profit, Operating, Gross MarginsCOST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), COST is creating value.
The number of shares outstanding for COST remains at a similar level compared to 1 year ago.
The number of shares outstanding for COST has been increased compared to 5 years ago.
Compared to 1 year ago, COST has an improved debt to assets ratio.
COST Yearly Shares OutstandingCOST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
COST Yearly Total Debt VS Total AssetsCOST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

COST has an Altman-Z score of 9.67. This indicates that COST is financially healthy and has little risk of bankruptcy at the moment.
COST has a better Altman-Z score (9.67) than 97.50% of its industry peers.
COST has a debt to FCF ratio of 0.78. This is a very positive value and a sign of high solvency as it would only need 0.78 years to pay back of all of its debts.
The Debt to FCF ratio of COST (0.78) is better than 87.50% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that COST is not too dependend on debt financing.
COST has a Debt to Equity ratio of 0.21. This is in the better half of the industry: COST outperforms 67.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.78
Altman-Z 9.67
ROIC/WACC2.27
WACC8.77%
COST Yearly LT Debt VS Equity VS FCFCOST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

COST has a Current Ratio of 1.02. This is a normal value and indicates that COST is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.02, COST is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.52 indicates that COST may have some problems paying its short term obligations.
COST has a Quick ratio (0.52) which is in line with its industry peers.
The current and quick ratio evaluation for COST is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.52
COST Yearly Current Assets VS Current LiabilitesCOST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.23% over the past year.
COST shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.11% yearly.
COST shows a small growth in Revenue. In the last year, the Revenue has grown by 5.94%.
The Revenue has been growing by 10.75% on average over the past years. This is quite good.
EPS 1Y (TTM)9.23%
EPS 3Y14.32%
EPS 5Y15.11%
EPS Q2Q%13.23%
Revenue 1Y (TTM)5.94%
Revenue growth 3Y9.1%
Revenue growth 5Y10.75%
Sales Q2Q%8.02%

3.2 Future

Based on estimates for the next years, COST will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.40% on average per year.
COST is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.62% yearly.
EPS Next Y11.86%
EPS Next 2Y11.17%
EPS Next 3Y10.86%
EPS Next 5Y9.4%
Revenue Next Year7.7%
Revenue Next 2Y7.6%
Revenue Next 3Y7.48%
Revenue Next 5Y6.62%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COST Yearly Revenue VS EstimatesCOST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100B 200B 300B 400B
COST Yearly EPS VS EstimatesCOST Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30

1

4. Valuation

4.1 Price/Earnings Ratio

COST is valuated quite expensively with a Price/Earnings ratio of 54.37.
COST's Price/Earnings ratio is a bit more expensive when compared to the industry. COST is more expensive than 75.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.24, COST is valued quite expensively.
Based on the Price/Forward Earnings ratio of 46.80, the valuation of COST can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COST indicates a slightly more expensive valuation: COST is more expensive than 62.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.82, COST is valued a bit more expensive.
Industry RankSector Rank
PE 54.37
Fwd PE 46.8
COST Price Earnings VS Forward Price EarningsCOST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

COST's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. COST is more expensive than 80.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of COST indicates a slightly more expensive valuation: COST is more expensive than 75.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 58.1
EV/EBITDA 33.35
COST Per share dataCOST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
COST has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.58
PEG (5Y)3.6
EPS Next 2Y11.17%
EPS Next 3Y10.86%

4

5. Dividend

5.1 Amount

COST has a yearly dividend return of 0.54%, which is pretty low.
Compared to an average industry Dividend Yield of 1.93, COST pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.54, COST pays less dividend than the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 0.54%

5.2 History

On average, the dividend of COST grows each year by 53.89%, which is quite nice.
COST has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)53.89%
Div Incr Years0
Div Non Decr Years0
COST Yearly Dividends per shareCOST Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

5.3 Sustainability

COST pays out 19.69% of its income as dividend. This is a sustainable payout ratio.
The dividend of COST is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP19.69%
EPS Next 2Y11.17%
EPS Next 3Y10.86%
COST Yearly Income VS Free CF VS DividendCOST Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
COST Dividend Payout.COST Dividend Payout, showing the Payout Ratio.COST Dividend Payout.PayoutRetained Earnings

COSTCO WHOLESALE CORP

NASDAQ:COST (8/22/2025, 8:00:36 PM)

After market: 958.177 -0.36 (-0.04%)

958.54

-11.14 (-1.15%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)05-29 2025-05-29/amc
Earnings (Next)09-25 2025-09-25/amc
Inst Owners71.83%
Inst Owner Change-1.53%
Ins Owners0.09%
Ins Owner Change-1.32%
Market Cap425.09B
Analysts78.14
Price Target1089.82 (13.7%)
Short Float %1.26%
Short Ratio2.66
Dividend
Industry RankSector Rank
Dividend Yield 0.54%
Yearly Dividend20.41
Dividend Growth(5Y)53.89%
DP19.69%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-01 2025-08-01 (1.3)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.51%
Min EPS beat(2)-4.04%
Max EPS beat(2)-0.98%
EPS beat(4)2
Avg EPS beat(4)0.45%
Min EPS beat(4)-4.04%
Max EPS beat(4)4.5%
EPS beat(8)5
Avg EPS beat(8)1.26%
EPS beat(12)6
Avg EPS beat(12)-0.44%
EPS beat(16)10
Avg EPS beat(16)1.2%
Revenue beat(2)0
Avg Revenue beat(2)-1.49%
Min Revenue beat(2)-1.94%
Max Revenue beat(2)-1.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.86%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)-1.05%
Revenue beat(8)0
Avg Revenue beat(8)-1.78%
Revenue beat(12)0
Avg Revenue beat(12)-2.05%
Revenue beat(16)1
Avg Revenue beat(16)-1.63%
PT rev (1m)-0.05%
PT rev (3m)-0.05%
EPS NQ rev (1m)-0.12%
EPS NQ rev (3m)-0.47%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)0.4%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.65%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 54.37
Fwd PE 46.8
P/S 1.58
P/FCF 58.1
P/OCF 34.21
P/B 15.67
P/tB 15.67
EV/EBITDA 33.35
EPS(TTM)17.63
EY1.84%
EPS(NY)20.48
Fwd EY2.14%
FCF(TTM)16.5
FCFY1.72%
OCF(TTM)28.02
OCFY2.92%
SpS606.06
BVpS61.16
TBVpS61.16
PEG (NY)4.58
PEG (5Y)3.6
Profitability
Industry RankSector Rank
ROA 10.39%
ROE 28.91%
ROCE 26.6%
ROIC 19.92%
ROICexc 32.76%
ROICexgc 32.76%
OM 3.75%
PM (TTM) 2.92%
GM 12.78%
FCFM 2.72%
ROA(3y)9.59%
ROA(5y)8.89%
ROE(3y)28.2%
ROE(5y)27%
ROIC(3y)18.6%
ROIC(5y)17.81%
ROICexc(3y)29.37%
ROICexc(5y)29.08%
ROICexgc(3y)30.8%
ROICexgc(5y)30.84%
ROCE(3y)24.84%
ROCE(5y)23.78%
ROICexcg growth 3Y-2.2%
ROICexcg growth 5Y2.32%
ROICexc growth 3Y-1.15%
ROICexc growth 5Y1.43%
OM growth 3Y-0.72%
OM growth 5Y3.3%
PM growth 3Y4.25%
PM growth 5Y3.86%
GM growth 3Y-0.71%
GM growth 5Y-0.57%
F-Score7
Asset Turnover3.56
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.78
Debt/EBITDA 0.46
Cap/Depr 216.67%
Cap/Sales 1.9%
Interest Coverage 84.03
Cash Conversion 99.87%
Profit Quality 93.29%
Current Ratio 1.02
Quick Ratio 0.52
Altman-Z 9.67
F-Score7
WACC8.77%
ROIC/WACC2.27
Cap/Depr(3y)207.83%
Cap/Depr(5y)199.15%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.77%
Profit Quality(3y)85.7%
Profit Quality(5y)103.11%
High Growth Momentum
Growth
EPS 1Y (TTM)9.23%
EPS 3Y14.32%
EPS 5Y15.11%
EPS Q2Q%13.23%
EPS Next Y11.86%
EPS Next 2Y11.17%
EPS Next 3Y10.86%
EPS Next 5Y9.4%
Revenue 1Y (TTM)5.94%
Revenue growth 3Y9.1%
Revenue growth 5Y10.75%
Sales Q2Q%8.02%
Revenue Next Year7.7%
Revenue Next 2Y7.6%
Revenue Next 3Y7.48%
Revenue Next 5Y6.62%
EBIT growth 1Y11.75%
EBIT growth 3Y8.31%
EBIT growth 5Y14.41%
EBIT Next Year40.12%
EBIT Next 3Y19.9%
EBIT Next 5Y14.7%
FCF growth 1Y25.66%
FCF growth 3Y7.27%
FCF growth 5Y14.57%
OCF growth 1Y26.17%
OCF growth 3Y8.17%
OCF growth 5Y12.27%